4BDA
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I04 |
Synchrotron site | Diamond |
Beamline | I04 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2008-12-17 |
Detector | ADSC CCD |
Spacegroup name | P 32 2 1 |
Unit cell lengths | 91.130, 91.130, 93.110 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 22.680 - 2.600 |
R-factor | 0.183 |
Rwork | 0.180 |
R-free | 0.23650 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2wtj |
RMSD bond length | 0.010 |
RMSD bond angle | 1.140 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | BUSTER (2.11.2) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 40.100 | 2.740 |
High resolution limit [Å] | 2.600 | 2.600 |
Rmerge | 0.080 | 0.480 |
Number of reflections | 14123 | |
<I/σ(I)> | 10.6 | 2.6 |
Completeness [%] | 99.8 | 99.9 |
Redundancy | 3.5 | 3.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 0.1 M HEPES 7.5, 0.2 M MG(NO3)2, 10% (V/V) ETHYLENE GLYCOL, 1 MM TCEP AND 8-14% (W/V) PEG 3350 |